To access this element change to forms mode OFF
Grant Award View - GA289069
Sugammadex, neostigmine and postoperative pulmonary complications
GA ID:
GA289069
Agency:
Department of Health and Aged Care
Approval Date:
9-Dec-2022
Publish Date:
20-Mar-2023
Category:
Medical Research
Grant Term:
1-Feb-2023 to 30-Apr-2027
Value (AUD):
$2,948,208.65
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 22/23 1.1 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
Sugammadex, neostigmine and postoperative pulmonary complications
Purpose:
Pneumonia and other lung complications after surgery are common, distressing and costly. Muscle weakness after surgery increases the risk of lung complications. Sugammadex reverses muscle relaxant drugs better than neostigmine. We propose a large study of surgical patients aged 40 years and over to determine if sugammadex reduces the risk of lung complications compared with neostigmine. This study has the potential to improve outcomes for millions of patients and health services worldwide.
GO ID:
GO Title:
MRFF 2021 Clinical Trials Activity Grant Opportunity
Internal Reference ID:
2022/MRF2022850
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA